标题
Genome Editing for Mucopolysaccharidoses
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 21, Issue 2, Pages 500
出版商
MDPI AG
发表日期
2020-01-15
DOI
10.3390/ijms21020500
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Identification of preexisting adaptive immunity to Cas9 proteins in humans
- (2019) Carsten T. Charlesworth et al. NATURE MEDICINE
- EMPOWERS: A phase 1/2 clinical trial of SB-318 ZFN-mediated in vivo human genome editing for treatment of MPS I (Hurler syndrome)
- (2019) Paul Harmatz et al. MOLECULAR GENETICS AND METABOLISM
- CHAMPIONS: A phase 1/2 clinical trial with dose escalation of SB-913 ZFN-mediated in vivo human genome editing for treatment of MPS II (Hunter syndrome)
- (2019) Joseph Muenzer et al. MOLECULAR GENETICS AND METABOLISM
- Precise Gene Editing Preserves Hematopoietic Stem Cell Function following Transient p53-Mediated DNA Damage Response
- (2019) Giulia Schiroli et al. Cell Stem Cell
- Hematopoietic Stem Cell Transplantation for Mucopolysaccharidoses: Past, Present, and Future
- (2019) Madeleine Taylor et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Induced Pluripotent Stem Cell Derivation and Ex Vivo Gene Correction Using a Mucopolysaccharidosis Type 1 Disease Mouse Model
- (2019) Toshio Miki et al. Stem Cells International
- Search-and-replace genome editing without double-strand breaks or donor DNA
- (2019) Andrew V. Anzalone et al. NATURE
- Human genome-edited hematopoietic stem cells phenotypically correct Mucopolysaccharidosis type I
- (2019) Natalia Gomez-Ospina et al. Nature Communications
- Neonatal nonviral gene editing with the CRISPR/Cas9 system improves some cardiovascular, respiratory, and bone disease features of the mucopolysaccharidosis I phenotype in mice
- (2019) Roselena Silvestri Schuh et al. GENE THERAPY
- UDiTaS™, a genome editing detection method for indels and genome rearrangements
- (2018) Georgia Giannoukos et al. BMC GENOMICS
- Worldwide distribution of common IDUA pathogenic variants
- (2018) E. Poletto et al. CLINICAL GENETICS
- Gene editing of MPS I human fibroblasts by co-delivery of a CRISPR/Cas9 plasmid and a donor oligonucleotide using nanoemulsions as nonviral carriers
- (2018) Roselena Silvestri Schuh et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- A novel Blind Start study design to investigate vestronidase alfa for mucopolysaccharidosis VII, an ultra-rare genetic disease
- (2018) Paul Harmatz et al. MOLECULAR GENETICS AND METABOLISM
- A Blood-Brain-Barrier-Penetrating Anti-human Transferrin Receptor Antibody Fusion Protein for Neuronopathic Mucopolysaccharidosis II
- (2018) Hiroyuki Sonoda et al. MOLECULAR THERAPY
- Dose-Dependent Prevention of Metabolic and Neurologic Disease in Murine MPS II by ZFN-Mediated In Vivo Genome Editing
- (2018) Kanut Laoharawee et al. MOLECULAR THERAPY
- p53 inhibits CRISPR–Cas9 engineering in human pluripotent stem cells
- (2018) Robert J. Ihry et al. NATURE MEDICINE
- CRISPR–Cas9 genome editing induces a p53-mediated DNA damage response
- (2018) Emma Haapaniemi et al. NATURE MEDICINE
- Gene Editing on Center Stage
- (2018) Rasmus O. Bak et al. TRENDS IN GENETICS
- CtIP fusion to Cas9 enhances transgene integration by homology-dependent repair
- (2018) M. Charpentier et al. Nature Communications
- Covalent linkage of the DNA repair template to the CRISPR-Cas9 nuclease enhances homology-directed repair
- (2018) Natasa Savic et al. eLife
- Prevalence of Pre-existing Antibodies to CRISPR-Associated Nuclease Cas9 in the USA Population
- (2018) Vijaya L. Simhadri et al. Molecular Therapy-Methods & Clinical Development
- Emerging Issues in AAV-Mediated In Vivo Gene Therapy
- (2018) Pasqualina Colella et al. Molecular Therapy-Methods & Clinical Development
- CRISPR-Cas9-mediated gene editing in human MPS I fibroblasts
- (2018) Talita Giacomet de Carvalho et al. GENE
- In vivo genome editing of mucopolysaccharidosis I mice using the CRISPR/Cas9 system
- (2018) Roselena Silvestri Schuh et al. JOURNAL OF CONTROLLED RELEASE
- Cas9-mediated allelic exchange repairs compound heterozygous recessive mutations in mice
- (2018) Dan Wang et al. NATURE BIOTECHNOLOGY
- A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cells
- (2018) Christopher A. Vakulskas et al. NATURE MEDICINE
- Disruption of the BCL11A Erythroid Enhancer Reactivates Fetal Hemoglobin in Erythroid Cells of Patients with β-Thalassemia Major
- (2018) Nikoletta Psatha et al. Molecular Therapy-Methods & Clinical Development
- ZFN-Mediated In Vivo Genome Editing Corrects Murine Hurler Syndrome
- (2018) Li Ou et al. MOLECULAR THERAPY
- Sangamo's landmark genome editing trial gets mixed reception
- (2018) Cormac Sheridan NATURE BIOTECHNOLOGY
- Genome surgery using Cas9 ribonucleoproteins for the treatment of age-related macular degeneration
- (2017) Kyoungmi Kim et al. GENOME RESEARCH
- Integrating Vectors for Gene Therapy and Clonal Tracking of Engineered Hematopoiesis
- (2017) Luca Biasco et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Genome and Epigenome Editing to Treat Disorders of the Hematopoietic System
- (2017) Claudio Mussolino et al. HUMAN GENE THERAPY
- Brain and Organ Uptake in the Rhesus Monkey in Vivo of Recombinant Iduronidase Compared to an Insulin Receptor Antibody–Iduronidase Fusion Protein
- (2017) Ruben J. Boado et al. MOLECULAR PHARMACEUTICS
- Hematopoietic Stem Cell Gene Therapy for Storage Disease: Current and New Indications
- (2017) Alessandra Biffi MOLECULAR THERAPY
- Programmable base editing of A•T to G•C in genomic DNA without DNA cleavage
- (2017) Nicole M. Gaudelli et al. NATURE
- Genome-wide target specificities of CRISPR RNA-guided programmable deaminases
- (2017) Daesik Kim et al. NATURE BIOTECHNOLOGY
- CIRCLE-seq: a highly sensitive in vitro screen for genome-wide CRISPR–Cas9 nuclease off-targets
- (2017) Shengdar Q Tsai et al. NATURE METHODS
- Single-cut genome editing restores dystrophin expression in a new mouse model of muscular dystrophy
- (2017) Leonela Amoasii et al. Science Translational Medicine
- Preclinical Testing of the Safety and Tolerability of Lentiviral Vector–Mediated Above-Normal Alpha-L-Iduronidase Expression in Murine and Human Hematopoietic Cells Using Toxicology and Biodistribution Good Laboratory Practice Studies
- (2016) Ilaria Visigalli et al. HUMAN GENE THERAPY
- Clinical course of sly syndrome (mucopolysaccharidosis type VII)
- (2016) Adriana M Montaño et al. JOURNAL OF MEDICAL GENETICS
- Hematopoietic stem cell transplantation for Morquio A syndrome
- (2016) Hiromasa Yabe et al. MOLECULAR GENETICS AND METABOLISM
- CRISPR/Cas9 β-globin gene targeting in human haematopoietic stem cells
- (2016) Daniel P. Dever et al. NATURE
- High-fidelity CRISPR–Cas9 nucleases with no detectable genome-wide off-target effects
- (2016) Benjamin P. Kleinstiver et al. NATURE
- Selection-free genome editing of the sickle mutation in human adult hematopoietic stem/progenitor cells
- (2016) M. A. DeWitt et al. Science Translational Medicine
- Enrichment of G2/M cell cycle phase in human pluripotent stem cells enhances HDR-mediated gene repair with customizable endonucleases
- (2016) Diane Yang et al. Scientific Reports
- Hematopoietic Cell Transplantation for Mucopolysaccharidosis Patients Is Safe and Effective: Results after Implementation of International Guidelines
- (2015) Mieke Aldenhoven et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- In vivo genome editing of the albumin locus as a platform for protein replacement therapy
- (2015) R. Sharma et al. BLOOD
- Cord blood is the optimal graft source for the treatment of pediatric patients with lysosomal storage diseases: clinical outcomes and future directions
- (2015) Mieke Aldenhoven et al. CYTOTHERAPY
- In vivo genome editing using Staphylococcus aureus Cas9
- (2015) F. Ann Ran et al. NATURE
- Increasing the efficiency of precise genome editing with CRISPR-Cas9 by inhibition of nonhomologous end joining
- (2015) Takeshi Maruyama et al. NATURE BIOTECHNOLOGY
- Chemically modified guide RNAs enhance CRISPR-Cas genome editing in human primary cells
- (2015) Ayal Hendel et al. NATURE BIOTECHNOLOGY
- Increasing the efficiency of homology-directed repair for CRISPR-Cas9-induced precise gene editing in mammalian cells
- (2015) Van Trung Chu et al. NATURE BIOTECHNOLOGY
- Digenome-seq: genome-wide profiling of CRISPR-Cas9 off-target effects in human cells
- (2015) Daesik Kim et al. NATURE METHODS
- Rationally engineered Cas9 nucleases with improved specificity
- (2015) I. M. Slaymaker et al. SCIENCE
- Pharmacological inhibition of DNA-PK stimulates Cas9-mediated genome editing
- (2015) Francis Robert et al. Genome Medicine
- Gene delivery strategies for the treatment of mucopolysaccharidoses
- (2014) Guilherme Baldo et al. Expert Opinion on Drug Delivery
- The effectiveness and cost-effectiveness of enzyme and substrate replacement therapies: a longitudinal cohort study of people with lysosomal storage disorders.
- (2014) K Wyatt et al. HEALTH TECHNOLOGY ASSESSMENT
- Efficacy and safety of enzyme replacement therapy with BMN 110 (elosulfase alfa) for Morquio A syndrome (mucopolysaccharidosis IVA): a phase 3 randomised placebo-controlled study
- (2014) Christian J. Hendriksz et al. JOURNAL OF INHERITED METABOLIC DISEASE
- GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases
- (2014) Shengdar Q Tsai et al. NATURE BIOTECHNOLOGY
- Genome-wide detection of DNA double-stranded breaks induced by engineered nucleases
- (2014) Richard L Frock et al. NATURE BIOTECHNOLOGY
- The new frontier of genome engineering with CRISPR-Cas9
- (2014) J. A. Doudna et al. SCIENCE
- Enhanced homology-directed human genome engineering by controlled timing of CRISPR/Cas9 delivery
- (2014) Steven Lin et al. eLife
- COSMID: A Web-based Tool for Identifying and Validating CRISPR/Cas Off-target Sites
- (2014) Thomas J Cradick et al. Molecular Therapy-Nucleic Acids
- Reading Frame Correction by Targeted Genome Editing Restores Dystrophin Expression in Cells From Duchenne Muscular Dystrophy Patients
- (2013) David G Ousterout et al. MOLECULAR THERAPY
- Outcomes of haematopoietic stem cell transplantation for inherited metabolic disorders: A report from the Australian and New Zealand Children's Haematology Oncology Group and the Australasian Bone Marrow Transplant Recipient Registry
- (2013) R. Mitchell et al. PEDIATRIC TRANSPLANTATION
- RNA-Guided Human Genome Engineering via Cas9
- (2013) P. Mali et al. SCIENCE
- Multiplex Genome Engineering Using CRISPR/Cas Systems
- (2013) L. Cong et al. SCIENCE
- RNA-programmed genome editing in human cells
- (2013) Martin Jinek et al. eLife
- Mucopolysacccharidoses: from understanding to treatment, a century of discoveries
- (2012) Roberto Giugliani GENETICS AND MOLECULAR BIOLOGY
- An exploratory study of brain function and structure in mucopolysaccharidosis type I: Long term observations following hematopoietic cell transplantation (HCT)
- (2012) Elsa Shapiro et al. MOLECULAR GENETICS AND METABOLISM
- Long-term efficacy of hematopoietic stem cell transplantation on brain involvement in patients with mucopolysaccharidosis type II: A nationwide survey in Japan
- (2012) Akemi Tanaka et al. MOLECULAR GENETICS AND METABOLISM
- Evaluation of miglustat as maintenance therapy after enzyme therapy in adults with stable type 1 Gaucher disease: a prospective, open-label non-inferiority study
- (2012) Timothy M Cox et al. Orphanet Journal of Rare Diseases
- A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity
- (2012) M. Jinek et al. SCIENCE
- Genistein in Sanfilippo disease: A randomized controlled crossover trial
- (2011) Jessica de Ruijter et al. ANNALS OF NEUROLOGY
- Enzyme replacement therapy for lysosomal storage diseases
- (2011) Robin H. Lachmann CURRENT OPINION IN PEDIATRICS
- Over-expression of RAD51 or RAD54 but not RAD51/4 enhances extra-chromosomal homologous recombination in the human sarcoma (HT-1080) cell line
- (2011) Shengli Yu et al. JOURNAL OF BIOTECHNOLOGY
- Evaluation of Miglustat Treatment in Patients with Type III Mucopolysaccharidosis: A Randomized, Double-Blind, Placebo-Controlled Study
- (2011) Nathalie Guffon et al. JOURNAL OF PEDIATRICS
- An unbiased genome-wide analysis of zinc-finger nuclease specificity
- (2011) Richard Gabriel et al. NATURE BIOTECHNOLOGY
- Improvement in hematological, visceral, and skeletal manifestations of Gaucher disease type 1 with oral eliglustat tartrate (Genz-112638) treatment: 2-year results of a phase 2 study
- (2010) E. Lukina et al. BLOOD
- Gene therapy augments the efficacy of hematopoietic cell transplantation and fully corrects mucopolysaccharidosis type I phenotype in the mouse model
- (2010) I. Visigalli et al. BLOOD
- Genome editing with engineered zinc finger nucleases
- (2010) Fyodor D. Urnov et al. NATURE REVIEWS GENETICS
- Guidelines for the Management of Mucopolysaccharidosis Type I
- (2009) Ana Maria Martins et al. JOURNAL OF PEDIATRICS
- Improved Metabolic Correction in Patients with Lysosomal Storage Disease Treated with Hematopoietic Stem Cell Transplant Compared with Enzyme Replacement Therapy
- (2009) Robert F. Wynn et al. JOURNAL OF PEDIATRICS
- Genistein reduces lysosomal storage in peripheral tissues of mucopolysaccharide IIIB mice
- (2009) Marcelina Malinowska et al. MOLECULAR GENETICS AND METABOLISM
- Strategies to Modulate Immune Responses: A New Frontier for Gene Therapy
- (2009) Valder R Arruda et al. MOLECULAR THERAPY
- Neutralizing antibodies to therapeutic enzymes: considerations for testing, prevention and treatment
- (2008) Jinhai Wang et al. NATURE BIOTECHNOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started